These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23472672)

  • 21. How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review.
    Vives-Pi M; Rodríguez-Fernández S; Pujol-Autonell I
    Apoptosis; 2015 Mar; 20(3):263-72. PubMed ID: 25604067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
    Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
    Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
    Citro A; Campo F; Dugnani E; Piemonti L
    Front Endocrinol (Lausanne); 2020; 11():606332. PubMed ID: 33628197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimers.
    Unger WW; Velthuis J; Abreu JR; Laban S; Quinten E; Kester MG; Reker-Hadrup S; Bakker AH; Duinkerken G; Mulder A; Franken KL; Hilbrands R; Keymeulen B; Peakman M; Ossendorp F; Drijfhout JW; Schumacher TN; Roep BO
    J Autoimmun; 2011 Nov; 37(3):151-9. PubMed ID: 21636247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide p277 of HSP60 signals T cells: inhibition of inflammatory chemotaxis.
    Nussbaum G; Zanin-Zhorov A; Quintana F; Lider O; Cohen IR
    Int Immunol; 2006 Oct; 18(10):1413-9. PubMed ID: 16893923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection.
    El Khatib MM; Sakuma T; Tonne JM; Mohamed MS; Holditch SJ; Lu B; Kudva YC; Ikeda Y
    Gene Ther; 2015 May; 22(5):430-8. PubMed ID: 25786871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astaxanthin and Corni Fructus protect against diabetes-induced oxidative stress, inflammation, and advanced glycation end product in livers of streptozotocin-induced diabetic rats.
    Park CH; Xu FH; Roh SS; Song YO; Uebaba K; Noh JS; Yokozawa T
    J Med Food; 2015 Mar; 18(3):337-44. PubMed ID: 25569034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation and type one diabetes.
    Bending D; Zaccone P; Cooke A
    Int Immunol; 2012 Jun; 24(6):339-46. PubMed ID: 22447815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
    Zhao Y; Yang L; Wang X; Zhou Z
    Diabetes Metab Res Rev; 2014 Nov; 30(8):646-53. PubMed ID: 24446278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
    van de Linde P; Vd Boog PJ; Tysma OM; Elliott JF; Roelen DL; Claas FH; de Fijter JW; Roep BO
    Clin Exp Immunol; 2007 Jul; 149(1):56-62. PubMed ID: 17459076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease-modifying immunotherapy for the management of autoimmune diabetes.
    Castro CN; Barcala Tabarrozi AE; Noguerol MA; Liberman AC; Dewey RA; Arzt E; Morelli AE; Perone MJ
    Neuroimmunomodulation; 2010; 17(3):173-6. PubMed ID: 20134195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 1 diabetes: can exercise impair the autoimmune event? The L-arginine/glutamine coupling hypothesis.
    Krause Mda S; de Bittencourt PI
    Cell Biochem Funct; 2008 Jun; 26(4):406-33. PubMed ID: 18383559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-cell replacement in immunosuppressed recipients: old and new clinical indications.
    Bertuzzi F; Ricordi C
    Acta Diabetol; 2007 Dec; 44(4):171-6. PubMed ID: 17924054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased hepatic ischemia-reperfusion injury by manganese-porphyrin complexes.
    Wu TJ; Khoo NH; Zhou F; Day BJ; Parks DA
    Free Radic Res; 2007 Feb; 41(2):127-34. PubMed ID: 17364938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells.
    Li X; Chen H; Epstein PN
    Diabetes; 2006 Jun; 55(6):1592-604. PubMed ID: 16731821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A; Santamaria P; Edelstein-Keshet L
    J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.